Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRua Life Sci. Regulatory News (RUA)

Share Price Information for Rua Life Sci. (RUA)

Share Price is delayed by 15 minutes
Get Live Data
19.50    -0.50 (-2.50%)
Bid:
19.00
Ask:
20.00
Spread: 1.00 (5.263%)
Market Cap: £12.10m
RUA Live PriceLast checked at - London Stock Exchange

Intraday Rua Life Sci. Share Chart

Director/PDMR Shareholding

14 Dec 2022 13:04

RNS Number : 7234J
RUA Life Sciences PLC
14 December 2022
 

14 December 2022

 

 

RUA Life Sciences Plc

 

("RUA Life Sciences", the "Company" or the "Group")

Director Dealing

 

RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the patented long-term implantable biostable polymer, Elast-EonTM, announces that it was notified on 14 December 2022 that Lachlan Smith, Chief Financial Officer, purchased 19,341 ordinary shares in the Company at 54.2p on 14 December 2022.

 

Following the purchase, Lachlan Smith owns 19,341 ordinary shares of the Company.

 

For further information contact:

 

RUA Life Sciences

Bill Brown, Chairman Tel: +44 (0)1294 317073

Caroline Stretton, Group Managing Director Tel: +44 (0)1294 317073

 

Cenkos Securities plc (Nominated Adviser and Broker) Tel: +44 (0)20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)

Michael Johnson (Sales)

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name:

Lachlan Smith via SIPP

2.

Reason for the notification

 

a)

Position/status:

Chief Financial Officer

 

b)

Initial notification/Amendment:

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name:

RUA Life Sciences plc

b)

LEI:

213800BMVB22PVOJ9Z28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 5 pence

GB0033360586

b)

Nature of the transaction:

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s):

Price(s)

54.17p

Volume(s)

19,341

d)

Aggregated information:

· Aggregated volume:

· Price:

 

n/a

e)

Date of the transaction:

14 December 2022

 

f)

Place of the transaction:

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFDFDLEESESE
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
22nd May 20267:00 amRNSTrading update for the 6-months ended 31/03/2026
12th May 20267:00 amRNSSpinout and Completion of Financing of RSH
17th Mar 20264:54 pmRNSResult of AGM
17th Mar 20267:00 amRNSAGM Statement and Trading Update
17th Mar 20267:00 amRNSAGM Statement and Trading Update
12th Feb 20261:35 pmRNSPosting of Annual Report and Notice of AGM
30th Jan 20267:00 amRNSFinal results for period ended 30 September 2025
10th Dec 20252:55 pmRNSCancellation & Reissue Share Options
4th Nov 20257:00 amRNSTrading update
25th Jun 20257:00 amRNS12 Month Interim Results
6th May 20259:30 amRNSDirector/PDMR Shareholding
30th Apr 202511:45 amRNSChange of Registered Office
24th Apr 20257:00 amRNSTrading Update
4th Feb 20257:00 amRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSAcquisition Update
29th Jan 20257:00 amRNSNew Supply Agreement
11th Dec 20247:00 amRNSInterim Results
30th Oct 20247:00 amRNSTrading Update & Change of Accounting Date
9th Sep 20247:00 amRNSAcquisition
28th Aug 20247:00 amRNSResult of AGM
27th Aug 20247:00 amRNSAGM Statement and Trading Update
24th Jul 20249:52 amRNSNew Material Project Win
24th Jul 20247:00 amRNSFinal Results
19th Jun 202410:18 amRNSBoard Changes, Issue of Options and PDMR Dealing
5th Apr 20248:30 amRNSBusiness Update
30th Jan 20247:00 amRNSChange of Auditor
29th Jan 20247:00 amRNSDirectorate Change
21st Dec 20235:30 pmRNSHolding(s) in Company
21st Dec 202312:00 pmRNSHolding(s) in Company
20th Dec 20237:00 amRNSHeart Valve Leaflet Material - Testing Update
19th Dec 20234:30 pmRNSHolding(s) in Company
18th Dec 20235:34 pmRNSN06/23 - Restoration of trading
18th Dec 20232:34 pmRNSResult of GM, Issue of Equity and TVR
18th Dec 20237:00 amRNSInterim Results
13th Dec 20232:30 pmRNSInvestor Presentation
11th Dec 20238:40 amRNSTemporary suspension of trading
11th Dec 20237:37 amRNSN05/23 - Trading Suspension
8th Dec 20237:00 amRNSResult of Retail Offer
1st Dec 20237:00 amRNSResult of Placing and Subscription
30th Nov 20235:51 pmRNSRetail Offer
30th Nov 20235:49 pmRNSPlacing and Subscription
24th Nov 20237:00 amRNSTrading Update
20th Nov 20237:00 amRNSStrategy Update
10th Nov 20231:30 pmRNSHolding(s) in Company
1st Nov 20235:30 pmRNSChange of Nominated Adviser and Broker
1st Sep 20238:04 amRNSDirectorate Change
23rd Aug 20234:18 pmRNSResult of AGM
22nd Aug 20237:00 amRNSAGM Statement and Trading Update
26th Jul 20237:00 amRNSFinal results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.